Camlin Fine Sciences Limited (CAMLINFINE) — Financial Results

1 Financial Results 🔴 High Importance Neutral 📄 PDF

The filing reports consolidated revenue of ₹32,618.86 lakh and a consolidated net loss of Rs. (350.27) lakh for the quarter ending March 31, 2026, reflecting a significant shift from prior performance, while the auditor confirms an unmodified opinion on the financial statements.

2 Financial Results Neutral 📄 PDF

Camlin Fine Sciences reported consolidated revenue of ₹17,233 crores for FY26, up from ₹16,287 crores in FY25, reflecting a 6.0% YoY increase. The company highlighted strong performance in specialty ingredients and blends, with blended revenue reaching Rs 569 mn in FY26. However, profitability faced pressure from rising input costs, currency fluctuations, and ongoing geopolitical tensions affecting raw material availability and pricing. Adjusted EBITDA margin stood at 5.0% for Q4 FY26, down from 6.8% in the prior quarter, driven by higher finance costs and exceptional items. The presentation emphasized strategic growth through acquisitions like Vinpai, targeting expansion in natural ingredients and improved vanillin realizations post-US tariff withdrawal.